Doan's Corrective Ads Unrelated To Consumer Misbeliefs - Novartis

The Federal Trade Commission failed to prove how ordering Novartis to run $8 mil. in advertising to remedy implied superiority claims for Doan's Pills, including 15-second TV spots containing no corrective statement, would "advance any governmental interest," the company's lawyer charged Feb. 8.